Products for Opioid Receptor
-
BCC5780
CTOP
-
BCC5776
CTAP
-
BCC6773
Naltrindole hydrochloride
Naltrindole hydrochloride is a highly potent and selective non-peptide δ opioid receptor antagonist with a Ki of 0.02 nM.
-
BCC6751
BRL 52537 hydrochloride
-
BCC6668
U-54494A hydrochloride
-
BCC6614
nor-Binaltorphimine dihydrochloride
Norbinaltorphimine dihydrochloride is a potent and selective κ opioid receptor antagonist.
-
BCC6666
(-)-U-50488 hydrochloride
-
BCC6656
(+)-U-50488 hydrochloride
-
BCC6792
ICI 199,441 hydrochloride
-
BCC5684
Clocinnamox mesylate
-
BCC7425
Cyprodime hydrochloride
-
BCC5757
Naloxone benzoylhydrazone
Naloxone benzoylhydrazone (NalBzoH) is a mixed agonist/antagonist. Naloxone benzoylhydrazone is a prototypic κ3-opioid receptor agonist, and a partial agonist at the cloned μ and δ opioid receptors, and an antagonist at opioid-like NOP receptors. Naloxone benzoylhydrazone has potently analgesia effect.
-
BCC6782
N-Benzylnaltrindole hydrochloride
-
BCC6806
ICI 204,448 hydrochloride
-
BCC5687
SB 205607 dihydrobromide
-
BCC5683
Naltriben mesylate
-
BCC6233
Deltorphin I
Deltorphin I is a δ-opioid receptor agonist with high affinity and selectivity.
-
BCC5723
[D-Ala2]-Deltorphin II
Deltorphin 2 is a selective peptide agonist for the δ opioid receptor.
-
BCC6090
Oxycodone hydrochloride
-
BCC7083
GR 89696 fumarate
-
BCC1719
LY2795050
LY2795050 is a novel selective κ-opioid Receptor (KOR) antagonist (IC50=0.72 nM) and has the potential as a PET tracer to image KOR in vivo.
-
BCC6308
ML 190
-
BCC1349
Alvimopan monohydrate
Alvimopan monohydrate (ADL 8-2698 monohydrate) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
-
BCC5697
Endomorphin-2
Endomorphin 2, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM.
-
BCC5954
Diprenorphine
-
BCC6799
DIPPA hydrochloride
-
BCC5798
BW 373U86
-
BCC1347
Alvimopan
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
-
BCC6785
SNC 80
SNC80 (NIH 10815) is a potent, highly selective and non-peptide δ-opioid receptor agonist with a Ki of 1.78 nM and an IC50 of 2.73 nM. SNC80 also selectively activates μ-δ heteromer in HEK293 cells with an EC50 of 52.8 nM. SNC80 shows antinociceptive, antihyperalgesic and antidepressant‐like effects. SNC80 has the potential for multiple headache disorders treatment.
-
BCC1783
Naltrexone
-
BCC4613
Naltrexone HCl
Broad spectrum opioid antagonist,Naltrexone HCl is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence.
-
BCC1348
Alvimopan dihydrate
Alvimopan dihydrate (ADL 8-2698 dihydrate) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
-
BCC7103
SNC 162
-
BCC5672
N-MPPP Hydrochloride
-
BCC6143
AR-M 1000390 hydrochloride
AR-M 1000390 hydrochloride is an exceptionally selective, potent δ opioid receptor agonist with an EC50 of 7.2±0.9 nM for δ agonist potency.
-
BCC3800
JTC-801
JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist, binding to ORL1 receptor with a Ki value of 8.2 nM.
-
BCC7054
SDM25N hydrochloride
-
BCC4380
Loperamide HCl
Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive
-
BCC7003
GNTI dihydrochloride
-
BCC4612
Naloxone HCl
Broad spectrum opioid antagonist,Naloxone HCl is an opioid inverse agonist drug used to counter the effects of opiate overdose.
-
BCC1670
JDTic
JDTic is a highly selective antagonist for the κ-opioid receptor; without affecting the μ- or δ-opioid receptors.
-
BCC4615
Trimebutine
Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.
-
BCC6368
Morphine hydrochloride
-
BCC5215
Buprenorphine hydrochloride
-
BCC6093
Nalmefene - d3
-
BCC5831
[Leu5]-Enkephalin
[Leu5]-Enkephalin is a pentapeptides with morphine like properties. [Leu5]-Enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors.
-
BCC7857
Nalmefene hydrochloride
-
BCC4920
Meptazinol HCl
Meptazinol is a unique centrally active opioid analgesic, which inhibits [3H]dihydromorphine binding with IC50 of 58 nM.
-
BCC6064
DADLE
-
BCC6665
(±)-U-50488 hydrochloride
-
BCC6850
β-Funaltrexamine hydrochloride
-
BCC1740
Methylnaltrexone Bromide
Methylnaltrexone (Bromide) is a <b>peripheral-acting opioid receptor</b> antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation.
-
BCC5718
DSLET
-
BCC5255
Oxymorphone
-
BCC5797
BAM 22P
BAM-22P, a highly potent opioid peptide, is a potent opioid agonist.
-
BCC6958
DAMGO
DAMGO is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR.
-
BCC1671
JDTic 2HCl
JDTic (dihydrochloride) is a potent antagonist of kappa-opioid receptors (KOR), blocking the κ-agonist U50, 488-induced antinociception.
-
BCC7596
Dynorphin A
-
BCC5987
Dynorphin B
Dynorphin B (1-13) acts as an agonist on opioid κ-receptor.
-
BCC5864
PL 017
-
BCC5677
ICI 154,129
-
BCC5875
Salvinorin A
-
BCC1265
ADL5859 HCl
ADL5859 is a δ-opioid receptor agonist with Ki of 0.8 nM, selectivity against opioid receptor κ, μ, and weak inhibitory activity at the hERG channel.
-
BCC7082
FIT
-
BCC1467
Cebranopadol
Cebranopadol is an analgesic NOP and opioid receptor agonist with Kis/EC50s of 0.9 nM/13 nM, 0.7 nM/1.2 nM, 2.6 nM/17 nM, 18 nM/110 nM for human NOP, MOP, KOP and delta-opioid peptide (DOP) receptor, respectively.
-
BCC6838
BNTX maleate
-
BCC6710
Naloxonazine dihydrochloride
-
BCC5758
DPDPE
-
BCC5675
ICI 174,864
-
BCC6000
Fentanyl citrate